Published in Am J Cardiol on June 15, 2002
Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy. J Nucl Cardiol (2010) 0.78
The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update. JACC Cardiovasc Imaging (2017) 0.75
Partial-volume effect in PET tumor imaging. J Nucl Med (2007) 5.81
The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol (2004) 4.55
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol (2004) 4.14
Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J (2004) 3.37
Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation (2004) 3.05
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging (2002) 2.95
We are all for elevating VR…. JACC Cardiovasc Imaging (2011) 2.62
Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol (2005) 2.47
The positron emission mammography/tomography breast imaging and biopsy system (PEM/PET): design, construction and phantom-based measurements. Phys Med Biol (2008) 2.31
Direct visualization of coronary sinus ostium and branches with a flexible steerable fiberoptic infrared endoscope. Heart Rhythm (2005) 2.08
Cardiorenal syndrome: new perspectives. Circulation (2010) 2.03
Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor. J Clin Oncol (2004) 1.85
Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation (2002) 1.74
Why all the focus on cardiac imaging? JACC Cardiovasc Imaging (2010) 1.68
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. J Nucl Cardiol (2002) 1.68
A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. J Card Fail (2008) 1.66
Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. Am Heart J (2006) 1.62
Effect of exposure to evidence-based pharmacotherapy on outcomes after acute myocardial infarction in older adults. J Am Geriatr Soc (2012) 1.58
Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data. J Nucl Med (2007) 1.49
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol (2013) 1.44
Exploration of patients' readiness for an eHealth management program for chronic heart failure: a preliminary study. J Cardiovasc Nurs (2008) 1.44
Pre-clinical myocardial metabolic alterations in chronic kidney disease. Cardiology (2010) 1.43
Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. JACC Cardiovasc Imaging (2010) 1.39
Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation (2005) 1.32
Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans. Eur J Nucl Med Mol Imaging (2002) 1.30
Integration of three-dimensional scar maps for ventricular tachycardia ablation with positron emission tomography-computed tomography. JACC Cardiovasc Imaging (2008) 1.29
American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr (2011) 1.28
Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging. Circulation (2011) 1.23
Vasopressin v(2) receptor blockade with tolvaptan versus fluid restriction in the treatment of hyponatremia. Am J Cardiol (2006) 1.23
Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes: a multicenter trial. J Am Coll Cardiol (2010) 1.22
B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. Am Heart J (2006) 1.20
Instrumentation quality assurance and performance. J Nucl Cardiol (2006) 1.20
Depression in heart failure: biobehavioral mechanisms. Heart Fail Clin (2011) 1.17
Simultaneous MRI and PET imaging of a rat brain. Phys Med Biol (2006) 1.14
Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial. Circulation (2007) 1.10
Simultaneous acquisition of magnetic resonance spectroscopy (MRS) data and positron emission tomography (PET) images with a prototype MR-compatible, small animal PET imager. J Magn Reson (2007) 1.09
Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol (2006) 1.09
Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model. Infect Immun (2010) 1.06
Simplified kinetic analysis of tumor 18F-FDG uptake: a dynamic approach. J Nucl Med (2004) 1.05
PET/CT imaging: effect of respiratory motion on apparent myocardial uptake. J Nucl Cardiol (2006) 1.05
Hypoxia, not the frequency of sleep apnea, induces acute hemodynamic stress in patients with chronic heart failure. J Am Coll Cardiol (2009) 1.05
Low-level ionizing radiation from noninvasive cardiac imaging: can we extrapolate estimated risks from epidemiologic data to the clinical setting? JACC Cardiovasc Imaging (2010) 1.04
SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med (2013) 1.04
The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure. J Am Coll Cardiol (2005) 1.03
Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose. Curr Cardiol Rep (2013) 0.98
Effects of sleep apnea on nocturnal free fatty acids in subjects with heart failure. Sleep (2011) 0.98
The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu]Cu-ATSM or [18F]Fluoromisonidazole positron emission tomography. Int J Oncol (2007) 0.98
Can positron emission tomography (PET) or PET/Computed Tomography (CT) acquired in a nontreatment position be accurately registered to a head-and-neck radiotherapy planning CT? Int J Radiat Oncol Biol Phys (2008) 0.98
The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer. Breast Cancer Res Treat (2002) 0.97
Molecular imaging of amyloidosis: will the heart be the next target after the brain? Curr Cardiol Rep (2012) 0.97
Three-dimensional contrast-enhanced multidetector CT for anatomic, dynamic, and perfusion characterization of abnormal myocardium to guide ventricular tachycardia ablations. Circ Arrhythm Electrophysiol (2010) 0.96
Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS). Am J Hematol (2006) 0.96
Variation of heart-to-mediastinal ratio in (123)I-mIBG cardiac sympathetic imaging: its affecting factors and potential corrections. Curr Cardiol Rep (2011) 0.94
Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms. PLoS One (2012) 0.94
Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. Clin Transl Sci (2011) 0.94
Imaging myocardial metabolism and ischemic memory. Nat Clin Pract Cardiovasc Med (2008) 0.94
How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction. Health Serv Res (2013) 0.93
Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Circulation (2002) 0.92
The characteristics and prognostic importance of NT-ProBNP concentrations in critically ill patients. Am J Med (2007) 0.92
Importance and management of chronic sleep apnoea in cardiology. Eur Heart J (2012) 0.91
Imaging myocardial metabolic remodeling. J Nucl Med (2010) 0.91
Quantification of radiotracer uptake with a dedicated breast PET imaging system. Med Phys (2008) 0.90
18F-FDG PET/CT in a recurrent diffuse malignant peritoneal mesothelioma. Clin Nucl Med (2012) 0.90
Adhesins and host serum factors drive Yop translocation by yersinia into professional phagocytes during animal infection. PLoS Pathog (2013) 0.90
Early imaging in heart failure: exploring novel molecular targets. J Nucl Cardiol (2007) 0.90
Clinical application of PET/CT fusion imaging for three-dimensional myocardial scar and left ventricular anatomy during ventricular tachycardia ablation. J Cardiovasc Electrophysiol (2009) 0.90
Yersinia pseudotuberculosis uses Ail and YadA to circumvent neutrophils by directing Yop translocation during lung infection. Cell Microbiol (2013) 0.89
Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice. JACC Cardiovasc Imaging (2008) 0.88
Strategies for defining an optimal risk-benefit ratio for stress myocardial perfusion SPECT. J Nucl Cardiol (2011) 0.88
Equilibrium radionuclide angiocardiography. J Nucl Cardiol (2006) 0.87
New York Heart Association functional class predicts exercise parameters in the current era. Am Heart J (2009) 0.86
Glucose and insulin variations in patients during the time course of a FDG-PET study and implications for the "glucose-corrected" SUV. Nucl Med Biol (2008) 0.86
Effect of plyometric training on swimming block start performance in adolescents. J Strength Cond Res (2009) 0.86
Association between depressive symptoms and fibrosis markers: the Cardiovascular Health Study. Brain Behav Immun (2009) 0.86
Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer. Mol Imaging Biol (2003) 0.85
Investigation of dynamic SPECT measurements of the arterial input function in human subjects using simulation, phantom and human studies. Phys Med Biol (2011) 0.85
18F-FDG PET/CT in a rare malignant extraskeletal osteosarcoma. Clin Nucl Med (2013) 0.85
The potential of FDG PET/CT for early diagnosis of cardiac device and prosthetic valve infection before morphologic damages ensue. Curr Cardiol Rep (2014) 0.85
Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation. Eur J Heart Fail (2012) 0.84
A gamma camera re-evaluation of potassium iodide blocking efficiency in mice. Health Phys (2007) 0.84
In hot blood: quantifying the arterial input function. JACC Cardiovasc Imaging (2013) 0.83
Test-retest reliability of assessment for intraventricular dyssynchrony by tissue Doppler imaging echocardiography. Am J Cardiol (2007) 0.83
Changes in psychosocial distress in outpatients with heart failure with implantable cardioverter defibrillators. Heart Lung (2008) 0.83
Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study. Clin Transl Sci (2010) 0.83
Assessment of myocardial viability by radionuclide and echocardiographic techniques: is it simply a sensitivity and specificity issue? Curr Opin Cardiol (2006) 0.83
Noninvasive assessment of right ventricular function: will there be resurgence in radionuclide imaging techniques? Curr Cardiol Rep (2010) 0.83
(18)F-fluorodeoxyglucose PET imaging of coronary atherosclerosis and plaque inflammation. Curr Cardiol Rep (2010) 0.82
Prognostic indicators: useful for clinical care? J Am Coll Cardiol (2009) 0.82
Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging. Circulation (2004) 0.82
Targeting tissue angiotensin-converting enzyme for imaging cardiopulmonary fibrosis. Curr Cardiol Rep (2008) 0.82
Screening asymptomatic patients with type 2 diabetes mellitus for coronary artery disease: does it improve patient outcome? Curr Cardiol Rep (2010) 0.82
From better understood pathogenesis to superior molecular imaging, and back... JACC Cardiovasc Imaging (2008) 0.82
Nuclear cardiac stress testing in the era of molecular medicine. J Nucl Med (2008) 0.81
Imaging left ventricular remodeling: targeting the neurohumoral axis. Nat Clin Pract Cardiovasc Med (2008) 0.81